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We appreciate the commentary by Berwick and Doré (1) on our study of the association 
between indoor tanning and melanoma (2). The commentary highlights our finding that 
indoor tanning is associated with younger age at diagnosis. We would point out however that 
our finding regarding the 2.2 years (95% CI: 0.9, 3.4 years) younger age at melanoma 
diagnosis on average among women with age of indoor tanning initiation <30 years compared 
with nonusers was statistically significant and not as it is stated in the commentary.      
In reaction to the increasing evidence on harmful effects of indoor tanning, the tanning 
industry has defended the practice on several grounds including questioning the causal 
association between indoor tanning and development of melanoma, recommending indoor 
tanning as a source of vitamin D, and claiming that indoor tanning is safer than the sun (3). 
The preliminary opinion of the European Commission Scientific Committee on Emerging and 
Newly Identified Health Risks was mentioned by Berwick and Doré. Our findings strongly 
support the Committee’s conclusion that sunbed exposure causes melanoma (4). We agree on 
the importance of large differences in the composition of ultraviolet (UV) wavelengths from 
indoor tanning devices and from the sun: erythema-weighted UV from indoor tanning devices 
is generally higher and the UVA irradiance is much higher. UVA has no role in vitamin D 
synthesis, which makes sunbeds an inefficient source to induce vitamin D compared to 
vitamin D supplements, which are widely available, cheaper, cause no skin damage, and more 
reliably raise vitamin D blood levels (5).However, we would question the suggested benefits 
of UV exposure raised in the commentary. So far, international regulations have focused on 
minimizing erythema, with little emphasis on the alarmingly high levels of UVA (6). UVA 
exposure does not increase melanin production and confers little or no protection against 
subsequent UV exposure. In general, UV exposure provides no protection against further UV 
exposure for many people who are not able to tan and offers far less protection than clothing 






























































and sunscreen for white skin. The evidence regarding the other possible benefits of UV 
exposure mentioned in the commentary is far from conclusive.  
We further agree with Berwick and Doré on the important role of Public Health authorities to 
strongly discourage use of indoor tanning, particularly by younger individuals. We would 
stress that the most effective way to do this is through legislation that restricts and ultimately 
bans carcinogenic exposure to UV for cosmetic purposes through use of sunbeds. The number 
of countries with nationwide indoor tanning legislations restricting use under 18 years is 
increasing, however, the compliance to legislations and their effectiveness are not evident (7). 
Some studies found age restriction effective in reducing indoor tanning prevalence among 
young women (8), while others found limited effectiveness (9, 10). The effectiveness of laws 
that prohibit tanning for minors cannot be fully realized without proper enforcement, and 
unsupervised indoor tanning devices are one potential challenge (11). In the US, there is a 
limited regulation at the federal level and an overall lack of consistency in regulations and 
enforcement in states resulted in a generally low compliance by indoor tanning facilities (12). 
Importantly, indoor tanning is common among young adults aged 18-25 yeas and therefore 
unaffected by age restrictions. Commercial indoor tanning was completely banned in Brazil in 
2009 and in Australia in 2015 (13). With the high rates of indoor tanning in Europe and North 
America beyond the teen years, it is time for the policymakers in these countries to take 
similar action and prohibit indoor tanning, thereby saving money and lives (14).  































































1. Berwick M, Doré J-F. Invited Commentary: Indoor tanning: a melanoma accelerator? Am J 
Epidemiol 2016; 
2. Ghiasvand R, Rueegg CS, Weiderpass E, et al. Indoor tanning and melanoma risk: long-term 
evidence from a prospective population-based cohort study. Am J Epidemiol 2016; 
3. Autier P, Dore JF, Breitbart E, et al. The indoor tanning industry's double game. Lancet 
2011;377(9774):1299-1301. 
4. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). 
Preliminary Opinion on Biological effects of ultraviolet radiation relevant to health with 
particular reference to sunbeds for cosmetic purposes. 2015. 
http://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_052.pdf (accessed 
on Septembert 19, 2016). 
5. Lim HW, James WD, Rigel DS, et al. Adverse effects of ultraviolet radiation from the use of 
indoor tanning equipment: time to ban the tan. J Am Acad Dermatol 2011;64(4):e51-e60. 
6. Nilsen LT, Hannevik M, Veierod MB. UV exposure from indoor tanning devices: A 
systematic review. Br J Dermatol 2016;174:730-740. 
7. Pawlak MT, Bui M, Amir M, et al. Legislation restricting access to indoor tanning throughout 
the world. Arch Dermatol 2012;148(9):1006-1012. 
8. Guy GP, Berkowitz Z, Jones SE, et al. State indoor tanning laws and adolescent indoor 
tanning. Am J Public Health 2014;104(4):E69-E74. 
9. Cokkinides V, Weinstock M, Lazovich D, et al. Indoor tanning use among adolescents in the 
US, 1998 to 2004. Cancer 2009;115(1):190-198. 
10. Mayer JA, Woodruff SI, Slymen DJ, et al. Adolescents' use of indoor tanning: a large-scale 
evaluation of psychosocial, environmental, and policy-level correlates. Am J Public Health 
2011;101(5):930-938. 
11. Holman DM, Fox KA, Glenn JD, et al. Strategies to reduce indoor tanning: current research 
gaps and future opportunities for prevention. Am J Prev Med 2013;44(6):672-681. 






























































12. Pan M, Geller L. Update on indoor tanning legislation in the United States. Clin Dermatol 
2015;33(3):387-392. 
13. Corbyn Z. Prevention: Lessons from a sunburnt country. Nature 2014;515(7527):S114-S116. 
14. Hirst N, Gordon L, Gies P, et al. Estimation of avoidable skin cancers and cost-savings to 




Page 5 of 5 American Journal of Epidemiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
